Your browser is no longer supported. Please, upgrade your browser.
ZTS [NYSE]
Zoetis Inc.
IndexS&P 500 P/E52.47 EPS (ttm)3.99 Insider Own0.10% Shs Outstand474.80M Perf Week1.58%
Market Cap99.38B Forward P/E41.01 EPS next Y5.11 Insider Trans-19.13% Shs Float472.99M Perf Month8.72%
Income1.91B PEG4.13 EPS next Q1.10 Inst Own92.80% Short Float0.78% Perf Quarter2.67%
Sales7.41B P/S13.41 EPS this Y9.90% Inst Trans-0.05% Short Ratio2.69 Perf Half Y20.09%
Book/sh9.16 P/B22.88 EPS next Y12.26% ROA13.80% Target Price224.58 Perf Year29.00%
Cash/sh- P/C- EPS next 5Y12.70% ROE48.30% 52W Range141.41 - 211.77 Perf YTD26.63%
Dividend1.00 P/FCF78.01 EPS past 5Y38.30% ROI14.90% 52W High-1.03% Beta0.64
Dividend %0.48% Quick Ratio2.50 Sales past 5Y7.00% Gross Margin69.70% 52W Low48.21% ATR3.63
Employees11300 Current Ratio3.40 Sales Q/Q25.80% Oper. Margin31.60% RSI (14)64.54 Volatility1.56% 1.72%
OptionableYes Debt/Eq1.65 EPS Q/Q36.10% Profit Margin25.80% Rel Volume1.18 Prev Close210.52
ShortableYes LT Debt/Eq1.52 EarningsNov 04 BMO Payout22.40% Avg Volume1.37M Price209.58
Recom1.70 SMA204.38% SMA503.31% SMA20015.96% Volume1,621,212 Change-0.45%
Aug-05-21Resumed Credit Suisse Outperform $206
Jul-16-21Downgrade Raymond James Outperform → Mkt Perform
Mar-08-21Upgrade Raymond James Mkt Perform → Outperform $166
Mar-08-21Upgrade BofA Securities Neutral → Buy $180
Sep-21-20Initiated Atlantic Equities Overweight $191
Aug-14-20Upgrade Edward Jones Hold → Buy
Aug-12-20Downgrade Gabelli & Co Buy → Hold
May-27-20Initiated Jefferies Buy $152
Jan-10-20Initiated Raymond James Mkt Perform
Sep-09-19Initiated Goldman Buy $145
Jul-01-19Downgrade BofA/Merrill Buy → Neutral $111 → $120
Jun-11-19Initiated Barclays Overweight $120
May-23-19Initiated Guggenheim Buy $114
May-03-19Downgrade Gabelli & Co Buy → Hold $108
Mar-20-19Initiated SunTrust Hold
Mar-04-19Upgrade Stifel Hold → Buy $97 → $110
Jan-23-19Initiated UBS Neutral $86
Oct-15-18Upgrade JP Morgan Neutral → Overweight
Aug-22-18Downgrade Stifel Buy → Hold $95
Aug-03-18Reiterated Stifel Buy $86 → $95
Oct-25-21 08:50AM  
Oct-18-21 05:06PM  
Oct-14-21 04:30PM  
12:10PM  
Oct-13-21 06:57AM  
Oct-08-21 07:40AM  
Sep-30-21 09:25AM  
Sep-28-21 09:11PM  
10:41AM  
Sep-20-21 11:40AM  
Sep-15-21 06:27AM  
Sep-13-21 08:30AM  
Sep-10-21 03:04PM  
Sep-07-21 10:37AM  
Aug-31-21 01:25PM  
01:23PM  
Aug-26-21 12:57PM  
Aug-18-21 04:26AM  
Aug-05-21 04:18PM  
02:31PM  
01:02PM  
08:35AM  
07:24AM  
07:00AM  
Aug-04-21 10:39AM  
09:14AM  
08:00AM  
Aug-02-21 09:45AM  
Jul-29-21 03:05PM  
Jul-27-21 11:40AM  
Jul-22-21 12:10PM  
Jul-20-21 08:04AM  
Jul-16-21 06:50PM  
01:54PM  
Jul-15-21 01:43PM  
Jul-08-21 08:10AM  
Jul-07-21 11:40AM  
Jul-02-21 09:35AM  
08:30AM  
Jul-01-21 10:51AM  
Jun-30-21 08:30AM  
Jun-29-21 07:29AM  
Jun-22-21 01:11PM  
Jun-17-21 10:36AM  
Jun-16-21 04:13PM  
10:44AM  
Jun-10-21 08:00AM  
Jun-03-21 08:00AM  
Jun-02-21 08:12AM  
May-31-21 05:16PM  
May-27-21 08:30AM  
May-24-21 08:30AM  
May-20-21 04:30PM  
May-19-21 08:00AM  
May-11-21 07:00AM  
May-10-21 11:40AM  
08:49AM  
May-06-21 07:30PM  
04:39PM  
09:47AM  
08:25AM  
07:00AM  
May-05-21 08:51AM  
May-03-21 05:29PM  
10:00AM  
Apr-30-21 02:13PM  
Apr-29-21 05:02PM  
Apr-22-21 11:40AM  
Apr-20-21 12:10PM  
Apr-19-21 10:05AM  
Apr-16-21 07:14AM  
Apr-13-21 09:39AM  
08:59AM  
Apr-01-21 06:25AM  
Mar-31-21 08:30AM  
07:59AM  
Mar-30-21 04:51PM  
Mar-26-21 09:53AM  
Mar-24-21 08:58AM  
Mar-21-21 10:28AM  
Mar-18-21 11:30AM  
Mar-17-21 11:40AM  
Mar-16-21 08:08AM  
07:32AM  
Mar-15-21 09:22AM  
Mar-13-21 09:34AM  
07:54AM  
Mar-11-21 02:24PM  
Mar-10-21 08:30AM  
Mar-09-21 07:57AM  
Mar-08-21 01:00PM  
10:04AM  
09:51AM  
08:31AM  
Mar-01-21 11:40AM  
Feb-24-21 08:30AM  
Feb-22-21 09:51AM  
08:30AM  
03:00AM  
Feb-17-21 10:08AM  
Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. The company offers vaccines, which are biological preparations to prevent diseases of the respiratory, gastrointestinal, and reproductive tracts or induce a specific immune response; anti-infectives that prevent, kill, or slow the growth of bacteria, fungi, or protozoa; and parasiticides that prevent or eliminate external and internal parasites that include fleas, ticks, and worms. It also provides other pharmaceutical products, which comprise pain and sedation, antiemetic, reproductive, and oncology products; dermatology products for itch associated with allergic conditions and atopic dermatitis; and medicated feed additives that offer medicines to livestock. In addition, the company offers portable blood and urine analysis systems, and point-of-care diagnostic products, including instruments and reagents, rapid immunoassay tests, reference laboratory kits, blood glucose monitors, and laboratory services; and other non-pharmaceutical products, including nutritionals and agribusiness services, as well as products and services in areas, such as biodevices, genetics tests, and precision livestock farming. It markets its products to veterinarians, livestock producers, and retail outlets, as well as third-party veterinary distributors through its sales representatives, and technical and veterinary operations specialists. The company was founded in 1952 and is headquartered in Parsippany, New Jersey.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Chen Heidi C.Executive Vice PresidentOct 25Option Exercise73.249,446691,82533,541Oct 26 04:38 PM
Chen Heidi C.Executive Vice PresidentOct 25Sale210.229,4461,985,73824,095Oct 26 04:38 PM
Lagano RoxanneExecutive Vice PresidentOct 22Sale208.031,315273,55920,244Oct 22 04:39 PM
Trawicki RomanExecutive Vice PresidentOct 01Option Exercise73.243,287240,7404,497Oct 04 04:08 PM
Trawicki RomanExecutive Vice PresidentOct 01Sale194.144,497873,0480Oct 04 04:08 PM
Lagano RoxanneExecutive Vice PresidentSep 23Sale202.171,315265,85421,559Sep 27 04:30 PM
PECK KRISTIN CChief Executive OfficerAug 25Option Exercise30.8912,000370,68043,424Aug 26 05:08 PM
PECK KRISTIN CChief Executive OfficerAug 25Sale203.5514,5002,951,48628,924Aug 26 05:08 PM
Reed Willie MDirectorAug 23Sale207.101,450300,2955,964Aug 24 04:51 PM
Lagano RoxanneExecutive Vice PresidentAug 23Sale207.079,6031,988,49422,874Aug 24 04:49 PM
Lagano RoxanneExecutive Vice PresidentJul 22Option Exercise55.0212,844706,67754,927Jul 26 05:56 PM
Lagano RoxanneExecutive Vice PresidentJul 22Sale199.1822,4504,471,61032,477Jul 26 05:56 PM
Trawicki RomanExecutive Vice PresidentJul 01Option Exercise73.243,285240,5935,702Jul 06 04:22 PM
Trawicki RomanExecutive Vice PresidentJul 01Sale187.004,492840,0041,210Jul 06 04:22 PM
PECK KRISTIN CChief Executive OfficerMay 25Option Exercise30.8912,000370,68045,924May 26 05:16 PM
PECK KRISTIN CChief Executive OfficerMay 25Sale175.4514,5002,544,02631,424May 26 05:16 PM
Knupp Catherine A.Executive Vice PresidentMay 20Sale175.168,2831,450,85053,642May 21 04:39 PM
Lagano RoxanneExecutive Vice PresidentMay 19Option Exercise52.036,000312,15548,083May 21 04:41 PM
Lagano RoxanneExecutive Vice PresidentMay 19Sale169.056,0001,014,30042,083May 21 04:41 PM
Chen Heidi C.Executive Vice PresidentMay 03Option Exercise55.0212,238673,33536,883May 04 04:16 PM
Kelly Robert EdwardExecutive Vice PresidentMay 03Option Exercise28.301,54843,80810,353May 04 04:21 PM
Chen Heidi C.Executive Vice PresidentMay 03Sale175.0112,2382,141,77224,645May 04 04:16 PM
Kelly Robert EdwardExecutive Vice PresidentMay 03Sale174.702,053358,6598,300May 04 04:21 PM
Chen Heidi C.Executive Vice PresidentApr 21Option Exercise55.0211,637640,26836,282Apr 22 04:40 PM
Chen Heidi C.Executive Vice PresidentApr 21Sale170.1411,6371,979,91924,645Apr 22 04:40 PM
Trawicki RomanExecutive Vice PresidentApr 15Option Exercise73.243,285240,5936,908Apr 19 04:03 PM
Trawicki RomanExecutive Vice PresidentApr 15Sale165.004,491741,0152,417Apr 19 04:03 PM
Kelly Robert EdwardExecutive Vice PresidentMar 01Option Exercise28.301,55043,86511,365Mar 03 04:25 PM
Kelly Robert EdwardExecutive Vice PresidentMar 01Sale156.112,055320,8069,310Mar 03 04:25 PM
PECK KRISTIN CChief Executive OfficerFeb 25Option Exercise30.8912,000370,68050,351Mar 01 04:19 PM
PECK KRISTIN CChief Executive OfficerFeb 25Sale158.3716,4272,601,47633,924Mar 01 04:19 PM
Lagano RoxanneExecutive Vice PresidentFeb 19Option Exercise41.836,000250,98048,083Feb 22 04:32 PM
Alaix Juan RamonDirectorFeb 19Option Exercise73.24133,0709,746,047347,377Feb 23 04:59 PM
SCULLY ROBERT WDirectorFeb 19Buy164.687,5901,249,9317,590Feb 23 06:47 PM
Alaix Juan RamonDirectorFeb 19Sale160.55133,07021,363,973214,307Feb 23 04:59 PM
Lagano RoxanneExecutive Vice PresidentFeb 19Sale167.886,0001,007,28042,083Feb 22 04:32 PM
Chen Heidi C.Executive Vice PresidentFeb 18Option Exercise55.0260033,01225,245Feb 22 04:31 PM
Chen Heidi C.Executive Vice PresidentFeb 18Sale170.04600102,02424,645Feb 22 04:31 PM
Trawicki RomanExecutive Vice PresidentFeb 17Option Exercise73.243,285240,5938,114Feb 18 04:54 PM
Trawicki RomanExecutive Vice PresidentFeb 17Sale165.824,491744,6983,623Feb 18 04:54 PM
David GlennChief Financial OfficerFeb 16Option Exercise73.2426,2851,925,11359,186Feb 18 04:56 PM
David GlennChief Financial OfficerFeb 16Sale168.9226,2854,439,96532,901Feb 18 04:56 PM
Kelly Robert EdwardExecutive Vice PresidentFeb 11Option Exercise28.301,55043,86510,758Feb 16 05:16 PM
Kelly Robert EdwardExecutive Vice PresidentFeb 11Sale161.152,054331,0028,704Feb 16 05:16 PM
Chen Heidi C.Executive Vice PresidentDec 01Option Exercise41.831,18049,35917,515Dec 03 05:16 PM
Chen Heidi C.Executive Vice PresidentDec 01Sale161.641,180190,73516,335Dec 03 05:16 PM
PECK KRISTIN CChief Executive OfficerNov 25Option Exercise30.896,500200,78538,374Nov 25 04:42 PM
PECK KRISTIN CChief Executive OfficerNov 25Sale161.5110,5001,695,81027,874Nov 25 04:42 PM
Lagano RoxanneExecutive Vice PresidentNov 19Option Exercise41.836,000250,98041,680Nov 20 04:47 PM
Lagano RoxanneExecutive Vice PresidentNov 19Sale164.066,000984,36035,680Nov 20 04:47 PM
Alaix Juan RamonDirectorNov 13Sale165.4691,74715,180,5614,266Nov 17 04:30 PM
Chen Heidi C.Executive Vice PresidentNov 02Option Exercise41.831,17949,31817,514Nov 03 04:47 PM
Chen Heidi C.Executive Vice PresidentNov 02Sale161.431,179190,32616,335Nov 03 04:47 PM